86
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The Demography and Etiology of Pediatric Enucleation in a Tertiary Eye Center in North China, 2001–2015

, &
Pages 95-101 | Received 09 Nov 2017, Accepted 06 Sep 2018, Published online: 16 Oct 2018
 

ABSTRACT

Purpose: To review the demography and etiology of pediatric enucleation over time.

Methods: Pediatric ophthalmic inpatients recruited and recorded (aged 0–14 years) at Shandong Eye Institute from January 2001 to December 2015 were reviewed. Changes during the three periods from 2001 to 2005, 2006 to 2010, and 2011 to 2015 were compared and analyzed.

Results: A total of 9307 pediatric inpatients were reviewed. Of these, 71 patients (71 eyes) who had been treated by enucleation were analyzed; 46 were boys (64.79%) and 25 were girls (35.21%). The mean age at enucleation was 9 (0–14) years. The pediatric enucleation rate during this 15-year period was 0.76% (71/9307), with a decreasing trend (< 0.001). From 2001 to 2005, the figure was 3.45% (43/1245); it dropped to 0.80% (26/3231) from 2006 to 2010 and then dropped further to 0.04% (2/4831) by 2015. Trauma (52.1%, 37/71) was the leading etiology. Overall, 89.2% (33 eyes) exhibited open globe injuries; 78.4% (29/37) of these involved boys. In the cases with open injuries, the mean age at the time of trauma was 6.0 (0–14) years and the mean age at enucleation was 11 (2–14) years. Retinoblastoma (RB) (22.5%, 16/71) was the second-most common etiology; 68.8% (11/16) of these cases involved girls and the mean age at enucleation was 2 (0–5) years.

Conclusion: A decrease in pediatric enucleation in North China, especially in Shandong Province, was observed over time, possibly because of better surgical techniques, improvements in the treatment of RB, and public health interventions in children.

Additional information

Funding

This work was supported by The National Natural Science Foundation of China [81600721].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.